Ipamorelin cortisol research suggests this peptide releases growth hormone without the cortisol spike seen with older GH peptides. The catch: that finding comes mostly from animal studies. TelosRX reviews what the evidence shows.
Ipamorelin has a reputation as the "clean" growth hormone peptide. You'll see that claim on almost every peptide site. But where does it come from, and how strong is it?
This review traces the ipamorelin cortisol story back to the original studies. We'll cover what researchers measured, what they didn't, and where the gaps are. No hype. Just the papers.
One note first. Ipamorelin is not FDA-approved for any use. Everything below describes research findings, not promised effects.
Why Cortisol Matters With Growth Hormone Peptides
Cortisol is your main stress hormone. Your adrenal glands release it when a signal called ACTH (a pituitary stress messenger) tells them to.
Many growth hormone releasing peptides, called GHRPs, act on the ghrelin receptor. That receptor sits in the pituitary and the brain. Stimulating it can release growth hormone. With some peptides, it also nudges ACTH, cortisol, and prolactin upward.
Why would anyone care? Chronically high cortisol is linked with poorer sleep, more belly fat, and blood sugar changes. So a GH peptide that raises cortisol partly works against itself. That's the problem ipamorelin was designed to solve.
The Evidence at a Glance
| Study | Model | What it measured | Key finding |
|---|---|---|---|
| Raun et al., 1998 | Rat cells, rats, swine | GH, ACTH, cortisol, prolactin, LH, FSH, TSH | Ipamorelin did not raise ACTH or cortisol beyond GHRH levels, even at very high doses |
| Arvat et al., 1997 | Healthy young adults | GH, prolactin, ACTH, cortisol after GHRP-2 and hexarelin | Both older GHRPs raised prolactin, ACTH, and cortisol |
| Gobburu et al., 1999 | Healthy men | Ipamorelin blood levels and GH response | Short half-life and a single GH pulse; cortisol not reported |
| Frieboes et al., 2004 | Healthy volunteers, overnight | Sleep EEG and hormones after hexarelin | Hexarelin raised ACTH, cortisol, and prolactin and reduced deep sleep |
| Beck et al., 2014 | Adults after bowel surgery | Safety and gut recovery with IV ipamorelin | Well tolerated; no significant benefit over placebo |
Now let's walk through each one.
Finding 1: The Original Selectivity Study (Swine, 1998)
Everything starts with a 1998 paper from Novo Nordisk scientists. It was titled, fittingly, "Ipamorelin, the first selective growth hormone secretagogue".
The team built ipamorelin as a five-amino-acid peptide. In rat pituitary cells, it released GH about as well as GHRP-6. In anesthetized rats and conscious pigs, its GH potency also matched GHRP-6.
Then they checked other hormones in pigs. Here's what they reported:
- GHRP-6 and GHRP-2 raised ACTH and cortisol.
- Ipamorelin did not, beyond levels seen with GHRH (the body's own GH-releasing hormone).
- That held even at doses more than 200 times the dose needed for a half-maximal GH response.
- None of the peptides changed FSH, LH, prolactin, or TSH in the pigs.
The authors called ipamorelin the first ghrelin-receptor agonist with GH selectivity similar to GHRH. That line is the root of the "clean GH peptide" label.
The limit: this was an animal study. Pig hormone responses don't always predict human ones. It's a strong signal, not a final answer.
Finding 2: Older GHRPs Do Raise Cortisol in Humans (1997)
To see why the 1998 result mattered, look at what older peptides do in people.
A 1997 Italian study gave GHRP-2 and hexarelin to healthy young adults. Both produced strong GH responses, larger than GHRH did. But both also raised prolactin, ACTH, and cortisol.
The researchers put it bluntly. The ACTH and cortisol release from these GHRPs was similar to that caused by CRH, the body's main stress-axis trigger. In other words, these peptides are not fully specific for GH.
This is the comparison that makes ipamorelin interesting. If older GHRPs activate the stress axis in humans, a selective one could, in theory, avoid that. Theory, though, still needs human data.
Finding 3: Cortisol, Hexarelin, and Sleep (2004)
A small 2004 study in Psychoneuroendocrinology gives a practical picture of why this matters. Researchers gave healthy young volunteers hexarelin at bedtime and tracked sleep and hormones overnight.
Hexarelin raised GH and prolactin through the night. It also raised ACTH and cortisol in the first half of the night. Deep sleep dropped.
The authors suggested the stress-axis activation may have disrupted sleep. That's a hypothesis, not a proven cause. Still, it shows how a cortisol side signal could matter in real life, especially for people who take GH peptides at night.
Important: this study tested hexarelin, not ipamorelin. We found no published human study tracking ipamorelin's effect on sleep hormones overnight.
Finding 4: How Ipamorelin Behaves in Humans (1999)
Human data on ipamorelin exists, but it's thin. The key paper is a 1999 pharmacokinetic study in healthy men.
Researchers gave five infusion doses, with eight men at each level. Here's what they found:
- Blood levels rose in proportion to dose.
- The terminal half-life was about 2 hours.
- Each dose produced a single GH pulse, peaking around 40 minutes.
- GH then fell back toward baseline.
That single, short pulse resembles natural GH release more than a constant flood. It's part of why ipamorelin gets described as "physiologic."
The gap: this paper modeled GH response. It did not report cortisol or prolactin. So it can't confirm the pig selectivity result in people.
Finding 5: The Surgical Trial (2014)
Ipamorelin's largest human trial had nothing to do with growth hormone goals. A 2014 Phase 2 study in the International Journal of Colorectal Disease tested it for gut recovery after bowel surgery.
Researchers gave IV ipamorelin or placebo twice daily for up to seven days. The study enrolled 117 adults. Ipamorelin was well tolerated. Adverse event rates were similar between groups. But time to tolerating solid food did not differ significantly from placebo.
For our question, this trial adds safety context in a sick, post-surgical population. It doesn't add hormone data, because cortisol wasn't a main endpoint.
So, Does Ipamorelin Raise Cortisol? A Plain Answer
Here's the honest scorecard.
| Question | Evidence level | What it suggests |
|---|---|---|
| Does ipamorelin avoid cortisol spikes in animals? | Moderate (one well-designed study) | Yes, in swine, even at high doses |
| Do older GHRPs raise cortisol in humans? | Moderate (several small human studies) | Yes, GHRP-2 and hexarelin do |
| Does ipamorelin avoid cortisol spikes in humans? | Limited | Plausible, but not directly confirmed in published data |
| Does ipamorelin raise prolactin? | Limited | No change seen in swine |
| Long-term hormone effects in humans? | Very limited | Unknown |
Studies suggest ipamorelin is more selective than older GHRPs. Human confirmation is the missing piece. Anyone claiming certainty is overstating the record.
What About CJC-1295 Plus Ipamorelin?
People often search for "CJC-1295 ipamorelin cortisol" because the two are commonly paired. The logic is simple. CJC-1295 mimics GHRH, and ipamorelin acts on the ghrelin receptor. Two different pathways can produce a larger GH pulse together.
CJC-1295 has its own human data. A 2006 study in the Journal of Clinical Endocrinology & Metabolism found it raised GH and IGF-1 for days after one injection. Its half-life was roughly six to eight days. No serious adverse reactions were reported.
GHRH-type signals are generally considered GH-specific. Still, we found no published human study measuring cortisol with the combination. So the pairing's cortisol profile is inferred from each part, not tested directly.
Curious whether this pairing fits your goals? You can review the CJC-1295 / Ipamorelin protocol through TelosRX's asynchronous intake. Both peptides are compounded, not FDA-approved, and any prescription is subject to medical approval by a licensed provider.
How Ipamorelin Compares With Other GH Peptides
Cortisol is only one axis. Here's a simplified research-based comparison of common options.
| Peptide | Pathway | Cortisol signal in research | Prolactin signal in research |
|---|---|---|---|
| Ipamorelin | Ghrelin receptor | Not seen in swine | Not seen in swine |
| GHRP-2 | Ghrelin receptor | Raised in humans | Raised in humans |
| Hexarelin | Ghrelin receptor | Raised in humans | Raised in humans |
| GHRP-6 | Ghrelin receptor | Raised in swine | Not seen in swine |
| Sermorelin / CJC-1295 | GHRH receptor | Not a typical concern | Not a typical concern |
For a wider tour of this peptide family, see our guide to six types of growth hormone peptides. If you're weighing a GHRH option instead, our ipamorelin vs sermorelin comparison covers the differences.
What the Research Doesn't Tell Us Yet
Good evidence reviews name their blind spots. Here are ipamorelin's:
- No long-term human hormone studies. We don't know how cortisol behaves over months of use.
- No direct human cortisol data in published trials. The key selectivity result is from pigs.
- Doses differ. Research used IV infusions. Real-world protocols often use under-the-skin injections.
- Few women studied. The main human PK study enrolled men only.
- Combination data is missing. Stacks like CJC-1295 plus ipamorelin haven't been formally tested for cortisol.
These gaps don't mean ipamorelin is unsafe. They mean confident claims outrun the data.
Who Should Pay Closer Attention to Cortisol?
For most people researching GH peptides, cortisol is a background detail. For some, it deserves a closer look before starting anything.
- People with known adrenal or pituitary conditions. Any peptide acting on the pituitary warrants specialist input.
- People with blood sugar concerns. Both GH and cortisol can push glucose upward.
- People with chronic sleep problems. Night-time stress hormones may affect sleep quality, as the hexarelin study hinted.
- People under heavy ongoing stress. Baseline cortisol patterns may already be off.
If any of these apply, mention it in your intake. A licensed provider can decide whether extra labs make sense. Our overview of sleep and hormone research covers how cortisol and GH interact overnight.
Practical Takeaways
If you're researching ipamorelin, a few sensible habits follow from the evidence:
- View "no cortisol" as a hypothesis. It's well supported in animals, not proven in people.
- Get baseline labs. A provider may check IGF-1, fasting glucose, and other markers before and during use.
- Track sleep and mood. Changes there are worth reporting to your provider.
- Use a regulated source. "Research use only" vials carry unknown purity and dose.
Regulatory status for compounded peptides also keeps shifting. Our explainer on the July 2026 FDA PCAC vote covers how advisory decisions affect access.
Frequently Asked Questions
Does ipamorelin increase cortisol?
In the original 1998 swine study, ipamorelin did not raise ACTH or cortisol beyond levels seen with GHRH, even at very high doses. Older peptides like GHRP-2 and GHRP-6 did. Direct published human cortisol data for ipamorelin is limited, so the human answer is plausible but not fully confirmed.
Does CJC-1295 with ipamorelin raise cortisol?
No published human study has measured cortisol with this exact combination. CJC-1295 acts like GHRH, which is generally considered GH-specific. Ipamorelin showed no cortisol rise in swine. The pairing's cortisol profile is therefore inferred from each component rather than tested directly in people.
Does ipamorelin raise prolactin?
In the 1998 swine study, ipamorelin did not change prolactin, FSH, LH, or TSH. In contrast, human studies found GHRP-2 and hexarelin raised prolactin. Human prolactin data specific to ipamorelin is scarce, so view the no-prolactin claim as research-supported but not definitive.
Why is ipamorelin called a selective GH secretagogue?
Its developers showed it released growth hormone about as well as GHRP-6 without raising ACTH or cortisol in pigs. That selectivity resembles GHRH, the body's own GH-releasing hormone. The label comes from that 1998 study, which named ipamorelin the first selective growth hormone secretagogue.
How long does ipamorelin stay in the body?
A 1999 study in healthy men found a terminal half-life of about 2 hours after IV infusion. Each dose triggered a single growth hormone pulse that peaked around 40 minutes, then faded. Under-the-skin injections may behave somewhat differently, and individual responses vary.
Is ipamorelin FDA-approved?
No. Ipamorelin is not FDA-approved for any use. Its original developer did not bring it to market, and human research remains limited. Some compounding pharmacies prepare it under federal compounding rules, which always requires a prescription from a licensed provider after evaluation.
TelosRX is LegitScript-certified. Compounded medications are not FDA-approved and are prepared under federal compounding regulations. Approval is subject to evaluation by a licensed provider; approval is not guaranteed. Individual results vary. TelosRX operates as an online-first, asynchronous telehealth service.
Start your private evaluation at TelosRX.